For the first nine months of 2014, UHS’ net income was $372.5 million, which lags behind the $386.2 million it reported for the same period last year.
Included in UHS’ reported financial results was a pre-tax charge of $44 million, which the hospital operator incurred in connection with a $65 million legal settlement. The settlement was related to a 2009 shareholder class-action lawsuit that was filed against Psychiatric Solutions — a UHA subsidiary — over allegedly misleading investors by failing to disclose information about violence at one of its psychiatric hospitals.
The financial report also included a $36.2 million pre-tax charge resulting primarily from UHS’ early redemption of its previously outstanding debt of $250 million that was scheduled to mature in 2018.
Like many other healthcare organizations, UHS is benefiting from an increased volume of insured patients, which contributed to the hospital operator’s revenue rising to $2.02 billion, an 11.1 percent increase over the third quarter of last year.
More articles on healthcare finance:
LifePoint reports strong Q3 financial results, expects trend to continue
For-profit hospital stock report: Week of Oct. 20-24
5 most-read finance stories: Week of Oct. 20-24
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
